Product Information
METOPROLOL SUCC ER 100 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.0850 per EA under NDC 69097040815. Its NADAC has been published 295 times since Feb 10, 2021.
FDA first approved this application on Oct 26, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Cipla USA Inc.NDC
69097040815
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOPROLOL SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA207465FDA Approved
10/26/2018
TE Code
AB
On Market Since
3/25/2019
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL SUCC ER 100 MG TAB has been published 295 times since Feb 10, 2021, and over the history we have for it it has declined 56.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0850 per EA |
|---|---|
| All-time high | $0.1970 (Feb 10, 2021) |
| All-time low | $0.0813 (Apr 22, 2026) |
| 52-week high | $0.0966 |
| 52-week low | $0.0813 |
| Median price | $0.1233 |
| Average price | $0.1264 |
| Largest weekly change | +47.2% (Mar 20, 2024) |
| Weeks tracked | 295 |
| Tracking since | Feb 10, 2021 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
metoprolol succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOPROLOL SUCC ER 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 100 MG TAB, manufactured by Cipla USA Inc., is $0.0850 per EA (NDC 69097040815), effective Sep 30, 2026.
How has the price of METOPROLOL SUCC ER 100 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL SUCC ER 100 MG TAB has declined 56.9%. It has been tracked across 295 weekly CMS publications since Feb 10, 2021.
What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 100 MG TAB?
Since Feb 10, 2021, the NADAC for METOPROLOL SUCC ER 100 MG TAB has ranged from a low of $0.0813 (Apr 22, 2026) to a high of $0.1970 (Feb 10, 2021), with a median of $0.1233 per EA.
Are there cheaper alternatives to METOPROLOL SUCC ER 100 MG TAB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METOPROLOL SUCC ER 100 MG TAB, is $0.0813 per EA — about 4% below METOPROLOL SUCC ER 100 MG TAB.
Who manufactures METOPROLOL SUCC ER 100 MG TAB?
METOPROLOL SUCC ER 100 MG TAB (NDC 69097040815) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.